Ennapadam Venkatraman

Author

Also Known As

E S Venkatraman, E Venkatraman, E. S. VENKATRAMAN, E. S. Venkatraman, E. Venkatraman, E.S Venkatraman, E.S. VENKATRAMAN, E.S. Venkatraman, Ennapadam S Venkatraman, Ennapadam S. Venkatraman

131

Publications

17.1K

Citations

H-Index

114

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University

About

Ennapadam Venkatraman is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	54	78	11.8K
2	Health Sciences	17	20	3.1K
3	Public Health	4	4	695
4	Engineering	2	2	246
5	Language Studies	1	1	16

Ennapadam Venkatraman

102

Publications

16.7K

Citations

H-Index

Page 1

	Year	Citations
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients Michael J. Zeléfsky, Zvi Fuks, Margie Hunt, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation MedicineRadiation TherapyMedicineHigh-dose Intensity	2002	772
Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer Vincent A. Miller, Mark G. Kris, Neelam Shah, Journal of Clinical Oncology	2004	744
Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib Gregory J. Riely, William Pao, DuyKhanh Pham, Clinical Cancer Research	2006	740
HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER Michael J. Zeléfsky, Zvi Fuks, Margie Hunt, The Journal of Urology	2001	689
Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial Martee L. Hensley, Robert G. Maki, Ennapadam Venkatraman, Journal of Clinical Oncology Unresectable LeiomyosarcomaSurgical OncologyPhase Ii TrialRadiation TherapyMedicine	2002	684
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer Michael J. Zeléfsky, Zvi Fuks, Laura Happersett, Radiotherapy and Oncology Radiation MedicineRadiation TherapyMedicineRadiation Therapy PlanningOncology	2000	544
High-Dose, Single-Fraction Image-Guided Intensity-Modulated Radiotherapy for Metastatic Spinal Lesions Yoshiya Yamada, Mark H. Bilsky, D. Michael Lovelock, International Journal of Radiation OncologyBiologyPhysics Medical ImagingRadiation TherapyMedicineSpinal OncologyMri-guided Radiation Therapy	2008	539
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma Valerie W. Rusch, Kenneth E. Rosenzweig, Ennapadam Venkatraman, Journal of Thoracic and Cardiovascular Surgery Surgical OncologyMalignant Pleural MesotheliomaPhase Ii TrialRadiation TherapySurgical Resection	2001	493
Representational Oligonucleotide Microarray Analysis: A High-Resolution Method to Detect Genome Copy Number Variation Robert Lucito, John Healy, Joan Alexander, Genome Research GeneticsGenetic EpidemiologyPathologyTranscriptomics TechnologyGenomics	2003	441
The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer Fabio Maria Vecchio, Vincenzo Valentini, Bruce D. Minsky, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyGastrointestinal OncologyColorectal SurgeryCancer RecurrenceMedicine	2005	422

Page 1